Inventor · disambiguated record
Zhifei Fu
Also filed as: FU ZHIFEI
9 granted patents·4 pending applications·6 citations·filing 2015–2022
77Inventor score
Files withZHANGZHOU PIEN TZE HUANG PHARM5GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY2MEDSHINE DISCOVERY INC2CHANGZHOU YINSHENG PHARMACEUTICAL CO LTD1CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD1
Top patents by PatentIndex Score
13 records- 0183US11286248B2Pyrazine-2(1H)-ketone compound acting as FGFR inhibitorZHANGZHOU PIEN TZE HUANG PHARM·Filed 2019·Granted Mar 29, 2022·3 cites·18 claims
- 0269US10100027B2Benzofuran analogue as NS4B inhibitorCHANGZHOU YINSHENG PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 16, 2018·2 cites·7 claims
- 0368US10654808B2Tyrosine kinase inhibitor and pharmaceutical composition comprising sameGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted May 19, 2020·1 cites·21 claims
- 0460US2025059169A1Pyrazole-1(2h)-phthalazinone compound and application thereofMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 0558US11603366B2Crystalline form and B crystalline form of pyrazine-2(1H)-ketone compound and preparation method thereofZHANGZHOU PIEN TZE HUANG PHARM·Filed 2020·Granted Mar 14, 2023·0 cites·15 claims
- 0657US11535609B2Pyrazine-2(1H)-ketone compound preparation methodZHANGZHOU PIEN TZE HUANG PHARM·Filed 2020·Granted Dec 27, 2022·0 cites·12 claims
- 0756US11680061B2Crystal forms C and E of pyrazin-2(1H)-one compound and preparation method thereforZHANGZHOU PIEN TZE HUANG PHARM·Filed 2020·Granted Jun 20, 2023·0 cites·14 claims
- 0856US11597722B2Crystal form D of pyrazine-2(1H)-ketone compound and preparation method thereforZHANGZHOU PIEN TZE HUANG PHARM·Filed 2020·Granted Mar 7, 2023·0 cites·9 claims
- 0952US2023094146A1Deuterated thienopyridine compoundMEDSHINE DISCOVERY INC·Filed 2021·Application pending·0 cites
- 1051US12398138B2FGFR inhibitor compound in solid form and preparation method thereforCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2020·Granted Aug 26, 2025·0 cites·3 claims
- 1149US2023365596A1Crystal forms of pyridopyrazole compounds and preparation method thereforGUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY·Filed 2021·Application pending·0 cites
- 1244US12240849B2Nitrogen-containing spiro derivative as RET inhibitorGUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY·Filed 2020·Granted Mar 4, 2025·0 cites·19 claims
- 1344US2019169140A1Ido1 inhibitor and preparation method and application thereofShandong luye pharmaceutical co ltd·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhifei Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →